Psyence Group Inc (CSE:PSYG) (CSE:PSYG)'s Tony Budden caught up with Proactive New York to discuss the the international biotechnology company with operations in South Africa's launch of its range of functional mushroom products under the GOODMIND banner.
Budden says the GOODMIND formula harnesses the power of adaptogens; non-toxic, non-psychoactive fungi, used for centuries in traditional medicine for their stress-relieving benefits.
To bring the products to the South African marketplace, Psyence partnered with Goodleaf, a leading wellness and lifestyle brand specializing in CBD with a premium range of products infused with African botanicals.